These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30481899)

  • 1. [Effects of tenofovir and telbivudine on HBV RNA in pregnant women with different genotypes of HBeAg-positive hepatitis B in Guizhou Province].
    Zhang BF; Cheng ML; Lu S; Wu J; Wu YY; Liu Q; Zhao XK; Li YY; Hu YX; Liu W
    Zhonghua Yi Xue Za Zhi; 2018 Nov; 98(43):3503-3508. PubMed ID: 30481899
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].
    Zhang BF; Cheng ML; Zhang Q; Zhao XK; Yu L; Yang J; Deng KS; Zhang LS; Wang J; Hu YX
    Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):945-950. PubMed ID: 30669789
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis B virus genotype is an independent prognostic factor of telbivudine and tenofovir treatment in hepatitis B surface antigen-positive pregnant women.
    Zhang B; Yu L; Cheng M; Zhang Q; Wu J; Yang J; Liu Q; Lu S; Zhao X; Deng K; Liu Y; Wang J; Zhao P
    Food Sci Nutr; 2022 Jan; 10(1):3-11. PubMed ID: 35035905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical characteristics of hepatic flare and efficacy of antiviral therapy in pregnant women with chronic hepatitis B virus infection].
    Ding Y; Sheng QJ; Zhang C; Wu YY; Yuan SY; Xia TT; An ZY; Dou XG
    Zhonghua Gan Zang Bing Za Zhi; 2019 Feb; 27(2):106-111. PubMed ID: 30818914
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical efficacy and safety in telbivudine- or tenofovir-treated hepatitis B e antigen-positive pregnant women.
    Deng H; Liang S; Xu M; Zhuo L; Gao H; Chen K; Shi Y; Li H; Jiao Q; Lin L; Lei Y; Liu H
    Antivir Ther; 2020; 25(1):33-41. PubMed ID: 32049069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of telbivudine and tenofovir disoproxil fumarate in preventing hepatitis B vertical transmission: A real-life practice.
    Liu J; Wang J; Yan T; Du D; Qi C; Cao F; Yao N; Yang Y; He Y; Tian Z; Ren D; Zhu L; Chen T; Zhao Y
    J Viral Hepat; 2019 Oct; 26(10):1170-1177. PubMed ID: 31177596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of tenofovir or telbivudine in preventing HBV vertical transmission for pregnancy.
    Zeng J; Zheng C; Li H
    Medicine (Baltimore); 2019 Apr; 98(14):e15092. PubMed ID: 30946367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Telbivudine for prevention of perinatal transmission in pregnant women infected with hepatitis B virus in immune-tolerant phase: a study of efficacy and safety of drug withdrawal].
    Sheng QJ; Ding Y; Li BJ; Bai H; Zhang C; Han C; Fan YX; Li YW; Dou XG
    Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):258-64. PubMed ID: 27470623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the efficacy and safety of tenofovir and telbivudine in interrupting mother-to-child transmission of hepatitis B virus.
    Zhu B; Lv X; Zhao Z; Chen L; Chen X; Li C; Li S; Dai E
    Medicine (Baltimore); 2021 Nov; 100(44):e27695. PubMed ID: 34871254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.
    Zheng MH; Shi KQ; Dai ZJ; Ye C; Chen YP
    Clin Ther; 2010 Apr; 32(4):649-58. PubMed ID: 20435234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact of cessation of antiviral therapy at delivery on postpartum liver function in mothers with chronic hepatitis B virus infection].
    Guo HJ; Gao YF; Liu HY; He HT; Huang MT; Cai DC; Liao DD; Li JN; Yin XR; Liu ZH; Hu J
    Zhonghua Gan Zang Bing Za Zhi; 2019 Feb; 27(2):112-117. PubMed ID: 30818915
    [No Abstract]   [Full Text] [Related]  

  • 12. Tenofovir rescue therapy in pregnant females with chronic hepatitis B.
    Hu YH; Liu M; Yi W; Cao YJ; Cai HD
    World J Gastroenterol; 2015 Feb; 21(8):2504-9. PubMed ID: 25741161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus serosurvey and awareness of mother-to-child transmission among pregnant women in Shenyang, China: An observational study.
    Sheng QJ; Wang SJ; Wu YY; Dou XG; Ding Y
    Medicine (Baltimore); 2018 Jun; 97(22):e10931. PubMed ID: 29851831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic hepatitis B in pregnant women: is hepatitis B surface antigen quantification useful for viral load prediction?
    Fujiko M; Chalid MT; Turyadi ; Ie SI; Maghfira ; Syafri ; Wahyuni R; Roni M; Patellongi I; Massi MN; Muljono DH
    Int J Infect Dis; 2015 Dec; 41():83-9. PubMed ID: 26571304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of nucleos(t)ide analogues to prevent hepatitis B virus mother-to-child transmission in pregnant women with high viremia: real life practice from China.
    Sheng Q; Ding Y; Li B; Han C; Li Y; Zhang C; Bai H; Wang J; Zhao L; Xia T; An Z; Zhang M; Dou X
    Int J Med Sci; 2018; 15(8):796-801. PubMed ID: 30008589
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of hepatitis B viral loads and viral antigen levels in child-bearing age women with and without pregnancy.
    Xu C; Liu J; Liu L; Bi Y; Xu B; Chen J; Xu B; Chen T; Hu Y; Zhou YH
    BMC Pregnancy Childbirth; 2018 Jul; 18(1):292. PubMed ID: 29980185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of combination antiviral therapy following childbirth in pregnant HBV carriers receiving telbivudine for prevention of mother-to-child transmission].
    Lu JF; Liu YL; Ma LN; Cao ZH; He ZM; Jin Y; Zhang SB; Chen XY
    Zhonghua Gan Zang Bing Za Zhi; 2015 Nov; 23(11):821-5. PubMed ID: 26743241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and safety of telbivudine in pregnant women to prevent perinatal transmission of hepatitis B virus].
    Han GR; Jiang HX; Wang GJ; Yue X; Wang CM; Kan NY; Wu MM
    Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):201-5. PubMed ID: 22475140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.
    Jourdain G; Ngo-Giang-Huong N; Harrison L; Decker L; Khamduang W; Tierney C; Salvadori N; Cressey TR; Sirirungsi W; Achalapong J; Yuthavisuthi P; Kanjanavikai P; Na Ayudhaya OP; Siriwachirachai T; Prommas S; Sabsanong P; Limtrakul A; Varadisai S; Putiyanun C; Suriyachai P; Liampongsabuddhi P; Sangsawang S; Matanasarawut W; Buranabanjasatean S; Puernngooluerm P; Bowonwatanuwong C; Puthanakit T; Klinbuayaem V; Thongsawat S; Thanprasertsuk S; Siberry GK; Watts DH; Chakhtoura N; Murphy TV; Nelson NP; Chung RT; Pol S; Chotivanich N
    N Engl J Med; 2018 Mar; 378(10):911-923. PubMed ID: 29514030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNA.
    Chan HL; Chan CK; Hui AJ; Chan S; Poordad F; Chang TT; Mathurin P; Flaherty JF; Lin L; Corsa A; Gaggar A; Subramanian GM; McHutchison JG; Lau G; Lee S; Gane EJ
    Gastroenterology; 2014 May; 146(5):1240-8. PubMed ID: 24462735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.